Dernières nouvelles
Information non disponible
Real-world outcomes of patients with hereditary angioedema with normal C1-inhibitor function and patients with idiopathic angioedema of unknown etiology in Canada
Article de revueAllergy Asthma Clin Immunol, 20 (1), 2024.
Safety of Direct Drug Provocation for the Evaluation of Penicillin Allergy in Low-Risk Adults
Article de revueJ Allergy Clin Immunol Pract, 12 (2), 2024.
The Disease Burden of Hereditary Angioedema: Insights from a Survey in French-Canadians from Quebec
Article de revueJ Immunol Res, 2024 , 2024.
A Patient Charter for Chronic Urticaria
Article de revueAdv Ther, 41 (1), 2024.
Bradykinin-induced angioedema in the emergency department
Article de revueInt J Emerg Med, 15 (1), 2022.
Portrait des allergies au pollen chez la population québécoise
Article de revueLe climatoscope, (3), 2021.
Patient and physician perceptions of seasonal allergic rhinitis and allergen immunotherapy: a parallel physician patient survey
Article de revueAllergy Asthma Clin Immunol, 16 , 2020.
Correction to: The International/Canadian Hereditary Angioedema Guideline
Article de revueAllergy Asthma Clin Immunol, 16 , 2020.
The International/Canadian Hereditary Angioedema Guideline
Article de revueAllergy Asthma Clin Immunol, 15 , 2019.
Impaired RASGRF1/ERK-mediated GM-CSF response characterizes CARD9 deficiency in French-Canadians
Article de revueJ Allergy Clin Immunol, 137 (4), 2016.